Advertisement

December 5, 2022

The changing face of cN0M0 Prostate Cancer being found with pN+ after surgery in the contemporary era: results of an international European Survey on disease management

  • Matteo Sacco,
  • Giorgio Gandaglia,
  • Kirsti Aas,
  • ...
  • Paolo Gontero,
  • Giancarlo Marra
  • on behalf of The YAU Prostate Cancer Working Group
Published online: December 05, 2022

December 2, 2022

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib

  • Guillermo de Velasco,
  • Teresa Alonso-Gordoa,
  • Alejo Rodríguez-Vida,
  • ...
  • Javier Afonso,
  • Susana Hernando Polo,
  • Úrsula Asensio
Published online: December 02, 2022

November 29, 2022

Evaluation of trends in treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) across Canada during the COVID-19 pandemic

  • Carlos E. Stecca,
  • Di Maria Jiang,
  • Zachary Veitch,
  • ...
  • Nimira Alimohamed,
  • Lori Wood,
  • Srikala S Sridhar
Published online: November 29, 2022

November 25, 2022

A phase I study of capivasertib in combination with abiraterone acetate in patients with metastatic castration-resistant prostate cancer

  • Neal Shore,
  • Begoña Mellado,
  • Satish Shah,
  • ...
  • Marie Cullberg,
  • Carlos Fernandez Teruel,
  • Thomas Morris
Published online: November 25, 2022

November 24, 2022

Development and Internal Validation of a nomogram predicting overall survival based on Log ODDS of positive lymph-nodes for post radical cystectomy patients in muscle invasive carcinoma of bladder.

  • Dr Keval N Patel,
  • Dr Abhijeet Salunke,
  • Dr Mohit Sharma,
  • ...
  • Dr Vikas Warikoo,
  • Dr Ganesh Bakshi,
  • Dr Shashank J Pandya
Published online: November 24, 2022

November 23, 2022

The Natural History of Renal-Cell Carcinoma with sarcomatoid differentiation, a Stage-by-Stage Analysis

  • Karl H. Tully,
  • Sebastian Berg,
  • Marco Paciotti,
  • ...
  • Steven L. Chang,
  • Quoc-Dien Trinh,
  • Matthew Mossanen
Published online: November 23, 2022

The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade

  • Diana Taheri,
  • Fatemeh Jahanshahi,
  • Alireza Khajavi,
  • ...
  • Leonardo Oliveira Reis,
  • Fatemeh Khatami,
  • Seyed Mohammad Kazem Aghamir
Published online: November 23, 2022

November 22, 2022

Prognostic role of Long-Chain Acyl-Coenzyme A Synthetase Family Genes in patients with clear cell renal cell carcinoma: A Comprehensive Bioinformatics Analysis Confirmed with External Validation Cohorts.

  • Mustafa Zafer Temiz,
  • Aykut Colakerol,
  • Salih Zeki Sonmez,
  • ...
  • Engin Kandirali,
  • Atilla Semercioz,
  • Ahmet Yaser Muslumanoglu
Published online: November 22, 2022

November 19, 2022

November 18, 2022

Prognostic model for clear-cell renal cell carcinoma based on natural killer cell-related genes.

  • Xuezhong Shi,
  • Mengyang Yuan,
  • Yongli Yang,
  • ...
  • Ani Dong,
  • Huili Zhu,
  • Xiaocan Jia
Published online: November 18, 2022

November 17, 2022

Predictors of Pelvic Lymph Nodal Metastasis in Penile Squamous Cell Carcinoma- Results from a Matched-Pair Analysis

  • Akash P. Sali,
  • Ashish Shah,
  • Gagan Prakash,
  • ...
  • Archi Aggarwal,
  • Sangeeta B. Desai,
  • Santosh Menon
Published online: November 17, 2022

Genomic and clinical prognostic factors in patients with advanced urothelial carcinoma receiving immune checkpoint inhibitors

  • Neal S. Chawla,
  • Nicolas Sayegh,
  • Nishita Tripathi,
  • ...
  • Neeraj Agarwal,
  • Sumanta K. Pal,
  • Abhishek Tripathi
Published online: November 17, 2022

Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer

  • Prachi Mehta,
  • Shwetabh Sinha,
  • Sheetal Kashid,
  • Debanjan Chakraborty,
  • Ritesh Mhatre,
  • Vedang Murthy
Published online: November 17, 2022

Incidence of benign renal masses in a contemporary cohort of patients receiving partial nephrectomy for presumed renal cell carcinoma

  • Varun Vijay,
  • Fjolla Hyseni Vokshi,
  • Michael Smigelski,
  • Shavy Nagpal,
  • William C. Huang
Published online: November 17, 2022

November 15, 2022

Distinct profiles of DNA repair activity define favorable-risk prostate cancer subtypes with divergent outcome

  • Nishwant Swami,
  • Tiffany Nguyen,
  • Ifeanyichukwu Ogobuiro,
  • ...
  • Sanoj Punnen,
  • Brandon A. Mahal,
  • Mohammed Alshalalfa
Published online: November 15, 2022

November 13, 2022

The changing landscape of systemic therapy in the treatment of synchronous metastatic hormone-sensitive prostate cancer

  • Edward Lambert,
  • Nicolaas Lumen,
  • Valerie Fonteyne,
  • ...
  • Geert Villeirs,
  • Kathia De Man,
  • Charles Van Praet
Published online: November 13, 2022

Treatment rechallenge with immune checkpoint inhibitors in advanced urothelial carcinoma

  • Dimitrios Makrakis,
  • Dimitra Rafailia Bakaloudi,
  • Rafee Talukder,
  • ...
  • Petros Grivas,
  • Ali Raza Khaki,
  • Vadim S. Koshki
Published online: November 13, 2022
Open Access

November 12, 2022

November 11, 2022

Multicenter database of patients with germ-cell tumors: a Latin American Cooperative Oncology Group Registry (LACOG 0515).

  • Diogo A. Bastos,
  • Aline Bobato Lara Gongora,
  • Carlos Dzik,
  • ...
  • Fabio A. Schutz,
  • Oren Smaletz,
  • Andre P. Fay
Published online: November 11, 2022
Open Access

November 10, 2022

Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

  • Marta Barrado Los Arcos,
  • Fernando López-Campos,
  • Marta López Valcarcel,
  • ...
  • Vérane Achard,
  • Shankar Siva,
  • Felipe Couñago
Published online: November 10, 2022

November 3, 2022

ATR inhibition in Advanced Urothelial Carcinoma

  • Ryan C Leibrandt,
  • Mei-Juan Tu,
  • Ai-Ming Yu,
  • Primo N Lara Jr.,
  • Mamta Parikh
Published online: November 03, 2022
Open Access

November 2, 2022

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma

  • Akram M. Shayeb,
  • Hannah Dzimitrowicz McManus,
  • Danielle Urman,
  • ...
  • Bradley McGregor,
  • Toni K. Choueiri,
  • Rana R. McKay
Published online: November 02, 2022

November 1, 2022

New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer

  • Omar Ayyash,
  • Jonathan Yabes,
  • Lee Hugar,
  • ...
  • Elizabeth Wulff-Burchfield,
  • Benjamin Davies,
  • Bruce Jacobs
Published online: November 01, 2022

October 28, 2022

Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis

  • Harshit Garg,
  • Karen M. Wheeler,
  • Furkan Dursun,
  • ...
  • Ian M. Thompson,
  • Robert S. Svatek,
  • Michael A. Liss
Published online: October 28, 2022

October 26, 2022

October 22, 2022

A Systematic Review of Published Clinical Trials in the Systemic Treatment of Adrenocortical Carcinoma: An Initiative Led on Behalf of the Global Society of Rare Genitourinary Tumors

  • Tiago Costa de Padua,
  • Laura Marandino,
  • Daniele Raggi,
  • ...
  • Alexander Kutikov,
  • Philippe E. Spiess,
  • Andrea Necchi
Published online: October 22, 2022

October 21, 2022

October 20, 2022

Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience

  • Albert Jang,
  • Ellen B. Jaeger,
  • Elisa M. Ledet,
  • ...
  • Oliver Sartor,
  • Pedro C. Barata,
  • Christopher R. Trevino
Published online: October 20, 2022

October 12, 2022

Prevalence and Natural History of Non-metastatic Castrate Resistant Prostate Cancer: A Population-Based Analysis

  • Amanda E. Hird,
  • Erind Dvorani,
  • Refik Saskin,
  • ...
  • Ronald Kodama,
  • Girish S. Kulkarni,
  • Robert K. Nam
Published online: October 12, 2022

Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly

  • Andrea Necchi,
  • Monika Joshi,
  • Rick Bangs,
  • ...
  • Thomas W. Flaig,
  • Philippe E. Spiess
  • on behalf of the Global Society of Rare Genitourinary Tumors (GSRGT) and the International Bladder Cancer Group (IBCG)
Published online: October 12, 2022

Management of Localized T1c Prostate Cancer Among Men 75 Years and Older: A National Cancer Database Study

  • Stephanie Gleicher,
  • Michael F. Basin,
  • Louis Arens,
  • Joseph Jacob,
  • Timothy Byler,
  • Elizabeth Ferry
Published online: October 12, 2022

October 11, 2022

Uretero-enteric Strictures After Robot Assisted Radical Cystectomy: Prevalence and Management Over Two Decades

  • Yousuf O. Ramahi,
  • Mohsin Shiekh,
  • Ayat A. Shah,
  • ...
  • Qiang Li,
  • Ahmed A. Hussein,
  • Khurshid A. Guru
Published online: October 11, 2022

Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy

  • Angelika Terbuch,
  • Gudrun Walser,
  • Michael Stotz,
  • Armin Gerger,
  • Florian Posch,
  • Thomas Bauernhofer
Published online: October 11, 2022
Open Access

October 8, 2022

September 24, 2022

Real World Data of Diagnosis, Survival, and Treatment Outcomes in Patients With Metastatic Non Clear Cell Renal Cell Carcinoma

  • Floriane Izarn,
  • Benoît Allignet,
  • Romane Gille,
  • ...
  • Eve-Marie Neidhardt,
  • Sylvie Négrier,
  • Aude Fléchon
Published online: September 24, 2022

September 23, 2022

Demographic Profiles and Survival Outcomes of Patients With Urachal Adenocarcinoma: A Rare Tumor of the Urachal Remnant

  • Prabhat Bhargava,
  • Vanita Noronha,
  • George John,
  • ...
  • Jyoti Bajpai,
  • Akhil Kapoor,
  • Kumar Prabhash
Published online: September 23, 2022

September 14, 2022

Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer

  • Lewis J. Thomas,
  • Ryan L. Steinberg,
  • Vignesh T. Packiam,
  • ...
  • Sarah L. Mott,
  • Kenneth G. Nepple,
  • Michael A. O'Donnell
Published online: September 14, 2022

September 10, 2022

Multimodal Management of Testicular Mesothelioma - A Retrospective Analysis From a Tertiary Cancer Care Centre

  • Narmadha Rathinasamy,
  • Santosh Menon,
  • Gagan Prakash,
  • ...
  • Nilesh Sabale,
  • Archi Agrawal,
  • Amit Joshi
Published online: September 10, 2022

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

  • Aino Siltari,
  • Ragnar Lönnerbro,
  • Karl Pang,
  • ...
  • Anders Bjartell,
  • Anssi Auvinen
  • PIONEER Consortium
Published online: September 10, 2022
Open Access

September 9, 2022

“Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil”

  • Denis L. Jardim,
  • Adriano Gonçalves e Silva,
  • Alexandre Saad Fere Lima Pompeo,
  • ...
  • Wilson Busato Jr,
  • Wladimir Alfer Junior,
  • Fernando Maluf
Published online: September 09, 2022
Open Access

September 8, 2022

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

  • Pär Stattin,
  • Marcus Westerberg,
  • Ingela Franck Lissbrant,
  • ...
  • Rachel Weinrib,
  • David Martinez,
  • Xabier Garcia-Albeniz
Published online: September 08, 2022
Open Access

September 7, 2022

Modern Active Surveillance in Prostate Cancer: A Narrative Review

  • Trent A Pattenden,
  • Dhanika Samaranayke,
  • Andrew Morton,
  • ...
  • Stephen Mark,
  • Nathan Lawrentschuk,
  • Isaac A Thangasamy
Published online: September 07, 2022

September 5, 2022

Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram

  • Antonio Cicione,
  • Giuseppe Simone,
  • Riccardo Lombardo,
  • ...
  • Hassan Abol-Enein,
  • Andrea Tubaro,
  • Cosimo De Nunzio
Published online: September 05, 2022

September 1, 2022

Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab

  • Kota Umeda,
  • Nobuyuki Tanaka,
  • Yota Yasumizu,
  • ...
  • Takeo Kosaka,
  • Ryuichi Mizuno,
  • Mototsugu Oya
Published online: September 01, 2022

August 29, 2022

August 28, 2022

Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma

  • Andrea Panunzio,
  • Gabriele Sorce,
  • Stefano Tappero,
  • ...
  • Maria Angela Cerruto,
  • Alessandro Antonelli,
  • Pierre I. Karakiewicz
Published online: August 28, 2022

August 26, 2022

Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature

  • Yiming Wang,
  • Guangjun Xu,
  • Haitao Yang,
  • Xiaolong Zhou,
  • Haitao Wen
Published online: August 26, 2022
Advertisement